Anticancer Agent Ukrain and Bortezomib Combination is Synergistic in 4T1 Breast Cancer Cells

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|14|3|466-472

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.14, Iss.3, 2014-03, pp. : 466-472

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of bortezomib in combination with cisplatin and 5fluorouracil on 4T1 breast cancer cells

By            

Molecular Medicine Reports, Vol. 8, Iss. 1, 2013-01 ,pp. : 277-281

Spandidos Publications

Access to resources Recommend Favorite

Synergistic Anti-Cancer Effects of Grape Seed Extract and Conventional Cytotoxic Agent Doxorubicin Against Human Breast Carcinoma Cells

By Sharma Girish  

Breast Cancer Research and Treatment, Vol. 85, Iss. 1, 2004-05 ,pp. : 1-12

Springer Publishing Company

Access to resources Recommend Favorite

IKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cells

By              

International Journal of Oncology, Vol. 44, Iss. 4, 2014-01 ,pp. : 1171-1176

Spandidos Publications

Access to resources Recommend Favorite

The anticancer agent YC-1 suppresses progestin-stimulated VEGF in breast cancer cells and arrests breast tumor development

By          

International Journal of Oncology, Vol. 42, Iss. 1, 2013-01 ,pp. : 179-187

Spandidos Publications

Access to resources Recommend Favorite

Synergistic effects of cisplatin and proteasome inhibitor bortezomib on human bladder cancer cells

By        

Oncology Letters, Vol. 10, Iss. 1, 2015-01 ,pp. : 560-564

Spandidos Publications

Access to resources Recommend Favorite